Solvay Pharma India Ltd.[Amalgamated] - Research Center
532447 DUPHARPH Group (N.A.) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Dec ' 10 | Dec ' 09 | Dec ' 08 | Dec ' 07 | Dec ' 06 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 294.28 | 242.18 | 201.64 | 167.77 | 144.09 |
| Expenses | |||||
| Material consumed | 118.60 | 106.85 | 86.28 | 70.26 | 63.51 |
| Manufacturing expenses | 4.16 | 3.72 | 3.05 | 2.54 | 2.30 |
| Personnel expenses | 33.74 | 26.48 | 21.38 | 18.82 | 17.31 |
| Selling expenses | 32.59 | 18.80 | 13.44 | 11.76 | 11.65 |
| Adminstrative expenses | 31.22 | 25.64 | 29.58 | 19.92 | 18.06 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 220.32 | 181.48 | 153.73 | 123.30 | 112.83 |
| Operating profit | 73.97 | 60.69 | 47.91 | 44.47 | 31.27 |
| Other recurring income | 4.98 | 3.06 | 3.71 | 3.21 | 3.22 |
| Adjusted PBDIT | 78.95 | 63.75 | 51.62 | 47.68 | 34.49 |
| Financial expenses | 0.49 | 0.49 | 0.48 | 0.31 | 0.23 |
| Depreciation | 3.20 | 4.57 | 1.33 | 4.97 | 4.59 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 75.26 | 58.69 | 49.81 | 42.40 | 29.67 |
| Tax charges | 24.99 | 20.63 | 17.41 | 14.78 | 10.79 |
| Adjusted PAT | 50.27 | 38.06 | 32.41 | 27.62 | 18.87 |
| Non recurring items | 0.58 | 0.72 | 0.40 | 0.50 | -0.14 |
| Other non cash adjustments | - | 1.25 | - | -0.12 | - |
| Reported net profit | 50.85 | 40.03 | 32.80 | 28.00 | 18.73 |
| Earnigs before appropriation | 153.02 | 125.37 | 98.96 | 92.42 | 72.03 |
| Equity dividend | 12.88 | 16.41 | 8.84 | 20.20 | 4.04 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | 2.14 | 2.79 | 1.50 | 3.06 | 0.57 |
| Retained earnings | 138.00 | 106.17 | 88.63 | 69.16 | 67.43 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis